2010

• Cantrell LA, Mendivil A, Gehrig PA, Boggess JF.
  Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience.
  Gynecol Oncol. 2010 May;117(2):260-5. Epub 2010 Feb 13.
  
• Cantrell LA, Westin SN, Van Le L.
  The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not effect progression-free or overall survival.
  Cancer. 2010 Nov 8
• Hanna RK, Soper JT.
  The Role of Surgery and Radiation Therapy in the Management of Gestational Trophoblastic Disease.
  Oncologist. 2010 May 23. [Epub ahead of print]

• Shafer A, Zhou C, Gehrig PA, Boggess JF, Bae-Jump VL.
  Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis.
  Int J Cancer. 2010 Mar 1;126(5):1144-54.

2009

• Alvarez Secord A, Bae-Jump V, Havrilesky LJ, Calingaert B, Clarke-Pearson DL, Soper JT, Gehrig PA.
  Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists.
  Int J Gynecol Cancer. 2009 Apr;19(3):447-54.
• Bae-Jump VL, Zhou C, Boggess JF, Gehrig PA.

  Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
  Cancer. 2009 May 29. [Epub ahead of print]

• Bland AE, Calingaert B, Secord AA, Lee PS, Valea FA, Berchuck A, Soper JT, Havrilesky L  
  Relationship between tamoxifen use and high risk endometrial cancer histologic types.
  Gynecol Oncol. 112:150-4, 2009
• Boggess JF, Gehrig PA, Cantrell L, Shafer A, Mendivil A, Rossi E, Hanna R.
  Perioperative outcomes of robotically assisted hysterectomy for benign cases with complex pathology.
  Obstet Gynecol. 2009 Sep;114(3):585-93.
• Buttin BM, Mengestha B, Busch RA, Goodfellow PJ, Rossi EC, Lurain JR, Singh DK, Mutch DG,  Schink JC.
  Characteristics of patients with clear cell carcinoma of the endometrium.
  Clinical Gynecol Oncol. Feb 2009, 112(2) Supplement S69.
• Cantrell LA, Mendivil A, Gehrig PA, Boggess JF.
  Survival Outcomes for Women Undergoing Type III Robotic Radical Hysterectomy for Cervical Cancer: A 3-Year Experience.
  Society of Gynecologic Oncology 40th Annual Meeting, February 2009, San Antonio, TX.
• Cantrell LA, Mendivil A, Zhou C, Gehrig PA, Bae-Jump VL.
  Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy.
  Society of Gynecologic Oncology 40th Annual Meeting, February 2009, San Antonio, TX Won Best Poster Prize Award at the SGO
• Cantrell L and Van Le L
  Management of VAIN
  in Gynecologic Oncology for Gynecologists: A Case-Based guide of management of Pre-invasive and early disease. Clarke-Pearson D and Soper J. 2009
• Clarke-Pearson DL.
  Clinical practice. Screening for ovarian cancer
  N Engl J Med. 2009 Jul 9;361(2):170-7.
• Fader AN, Boruta D, Olawaiye AB, Gehrig PA.
  Uterine papillary serous carcinoma: epidemiology, pathogenesis and management.
  Curr Opin Obstet Gynecol. 2009 Nov 26 doi: 10.1097/GCO.0b013e328334d8a3
• Fader AN, Drake RD, O'Malley DM, Gibbons HE, Huh WK, Havrilesky LJ, Gehrig PA, Tuller E, Axtell AE, Zanotti KM; Uterine Papillary Serous Carcinoma (UPSC) Consortium.
  Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.
  Cancer. 2009 May 15;115(10):2119-27.

• Gehrig PA, Bae-Jump VL.
  Promising novel therapies for the treatment of endometrial cancer.
  Gynecol Oncol. 2009 Nov 8

• Hanna R, Cantrell LA, Gehrig PA, Mendivil A, Boggess JF.
  A cost analysis of robotic as compared to conventional laparoscopy for endometrial cancer staging.
  Society of Gynecologic Oncology 40th Annual Meeting, February 2009, San Antonio, TX.
• Hanna RK, Cantrell LA, Mendivil A, Gehrig PA, Boggess, JF
  A cost analysis of robotic as compared to conventional laparoscopy for endometrial cancer staging.
  Gynecol Oncol. 2009 Feb; 112 (2) Supplement: S166.
• Havrilesky LJ, Secord AA, O’Malley DM, Broadwater G, Bae-Jump V, Tatagari J, Hamamci N, Gehrig PA.
  Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
  Society of Gynecologic Oncology 40th Annual Meeting, February 2009, San Antonio, TX.
• Havrilesky LJ, Secord AA, O'Malley DM, Broadwater G, Bae-Jump V, Cohn DE, Gehrig PA.
  Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
  Gynecol Oncol. 2009 Aug;114(2):279-83. Epub 2009 May 15.
• Mendivil A, Cantrell LA, Shafer A, Gehrig PA, Boggess JF.
  Robotic Surgery Training in Gynecologic Oncology: A Comparion of Fellow/Attending Surgical Times.
  Society of Gynecologic Oncology 40th Annual Meeting, February 2009, San Antonio, TX
• Mendivil A, Holloway RW, Boggess JF.
  Invited Review: Emergence of Robotic Assisted Surgery in Gynecologic Oncology.
  2009 Gynecol Oncol, doi:10.1016/j.ygyno.2009.02.002
• Mendivil A, Holloway RW, Boggess JF.
  Emergence of robotic assisted surgery in gynecologic oncology: American perspective.
  Gynecol Oncol. 2009 Aug;114(2 Suppl):S24-31. Review.
• Mendivil A, Schuler KM, Gehrig PA.
  Invited Review: Non-Endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes.
  2009 Cancer Control, 16(1): 46-52.
• Milam MR, Abaid L, Reis RD, Frumovitz M, Gehrig PA, Livasy C, Broaddus RR, Ramirez PT.
  Microscopic Evaluation of Lymph-Node-Bearing Tissue in Early-Stage Cervical Cancer: A Dual-Institution Review.
  Ann Surg Oncol. 2009 Dec 29
• Rossi E, Soper J.
  Molar Pregnancies.
  BMJ Point-of-Care 2009; www.pointofcare.bmj.com.
• Saig R, Abaid L, Rutledge T, Gehrig PA.
  Hormonal treatment of complex endometrial hyperplasia and cancer.
  American College of Obstetrics and Gynecology 57th Annual Meeting, May 2009, Chicaco, IL
• Secord AA, Havrilesky LJ, O’Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA.
  A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
  Society of Gynecologic Oncology 40th Annual Meeting, February 2009, San Antonio, TX
• Shafer A, Ayeni TA, Deal AM, Secord AA, Soper JT, Havrilesky LJ, Van Le L, Gehrig PA.
  Improved Survival with Consolidation Chemotherapy After Adjuvant Paclitaxel and Carboplatin in Advanced Epithelial Ovarian Cancer (EOC).
  Society of Gynecologic Oncology 40th Annual Meeting, February 2009, San Antonio, TX.
• Shafer A and Van Le L
  Management of complex hyperplasia
  in Gynecologic Oncology for Gynecologists: A Case-Based guide of management of Pre-invasive and early disease. Clarke-Pearson D and Soper J. 2009
• Shafer A, Zhou C, Gehrig PA, Boggess JF, Bae-Jump VL.
  Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis.
  Int J Cancer. 2009 Aug 17. [Epub ahead of print]
• Van Le L.
  Commentary SGO staging handbook:
  Ovarian cancer staging. 2009
• Van Le L.
  Stage IC ovarian cancer: the clinical significance of  intraoperative rupture.
  Obstet Gynecol 2009; 113:4-5.

2008

• Bae-Jump VL, Zhou C, Boggess JF, Gehrig PA.
  Arsenic trioxide inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase pathway in endometrial cancer cells.
  Reproductive Sciences 2008; 15:1011-7.
• Bakelar RT, Soper JT, Lutman CV
  Cutaneous malignant melanoma metastatic to a uterine leiomyoma.
  J Reprod Med 53: 697-9, 2008
• Batal I, Domsic RT, Shafer A, Medsger TA Jr, Kiss LP, Randhawa P, and Bastacky S.
  Renal biopsy findings predicting outcome in scleroderma renal crisis.
  Hum Pathol. 2008 Oct 28 [Epub ahead of print]
• Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, Skinner EN, and Fowler WC.
  A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy.
  Am J Obstet Gynecol. 2008 Oct;199(4):360.e1-9
• Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, Skinner EN, Fowler WC.
  A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy.
  Am J Obstet Gynecol. 2008 Oct;199(4):357.e1-7
• Carlson JW, Kauderer J, Walker JL, Gold MA, O’Malley D, Tuller E, Clarke-Pearson DL.
  Phase III trial of Tisseel to reduce lymphedema after inguinal lymphnode dissection:  A Gynecologic Oncology Group Study.
  Gynecol Oncology, 2008; 110: 76-82.
• Clarke-Pearson DL, Abaid L.
  Emergency Management of DVT/PE.
  In The 5-Minute OB/GYN Clinical Consult (Ed.  Paula J. Hilliard).  Lippincott Williams and Wilkins (2008)
• Clarke-Pearson DL. Abaid L.
  Prevention of Deep Vein Thrombosis and Pulmonary Embolism.
  ACOG Practice Bulletin  American College of Obstetricians and Gynecologists, Washington DC, 2008
• Clarke-Pearson DL, Picklesimer A.  
  Management of DVT/PE in Pregnancy.  In The 5-Minute OB/GYN Clinical Consult (Ed.  Paula J. Hilliard).
  Lippincott Williams and Wilkins (2008)
• Gehrig PA, Cantrell L, Shafer A, Abaid L, Mendivil A, Boggess JF.
  What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?
  Gynecologic Oncology 2008; 111: 41-5.
• Greene, MH, Piedmonte, M, Alberts, D, Gail, M, Hensley, M, Miner, Z, Mai, PL, Loud, J, Rodriguez, G, Basil, J, Boggess J, Schwartz, PE, Kelley, JL, Wakeley, KE, Minasian, L, Skates,. S.
  A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer: Design and Baseline Characteristics: A Gynecologic Oncology Group Study.
  Cancer Epidemiology Biomarkers & Prevention 2008 17, 594-604.
• Martino M, Rajaram L, Maxwell GL, Clarke-Pearson DL.
  Combination Prophylaxis for Thromboembolism Prevention among Gynecologic Oncology Patients Perioperatively.
  Gynecol Oncol 2008; 109: 426-27.
• Mettler L, Schollmeyer T, Boggess J, Magrina JF, Oleszczuka A.
  Robotic Assistance in Gynecological Oncology.
  Curr Opin Oncol 20:581–589, 2008.
• Moayeri SE,  Allen RB, Brewster WR, Kim MH, Porto M, Werlin LB 
  Day-3 embryo morphology predicts euploidy among older subjects.
  Fertil Steril. 2008 Jan 89(1):118-23.
• Shafer A, Boggess JF.
  Robotic-assisted endometrial cancer staging and radical hysterectomy with the da Vinci® surgical system.
  Gynecologic Oncology, 2008, Sep 2. [Epub ahead of print]
  

2007

• Bae Jump V, Bauer M, Van Le L.
  Cytologic Evaluation Correlates Poorly with Histologic Diagnosis of Vulvar Neoplasias.
  Journal of Lower Genital Tract Disease 2007; 11:8-11.
• Alvarez A, Laura J Havrilesky, Bae-Jump V, Chin JR, Calingaert B, Bland AE, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA.
  The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer
  Gynecol Oncol 2007; 107: 285-91
• Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA.
  The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
  Gynecol Oncol. 2007;107(2):285-91
• Alvarez Secord, A., Havrilesky, L.J., Carney, M.E., Soper, J.T., Clarke-Pearson, D.L., Rodriguez, G. C., Berchuck, A: 
  A phase II study of weekly low dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer.
  Int J of Clin Oncol  12(1):31-6, 2007.
• Bae-Jump, V; Boggess, J.
  Cervical Neoplasia.
  In Greganti, Runge (Second Edition) Netter’s Textbook of Internal Medicine. Chapter 90, pages 594-600. ICON Learning Systems LLC. 2007.
• Bae-Jump, VL, Bauer, M and Van Le, L,
  Cytologic Evaluation Correlates Poorly with Histologic Diagnosis of Vulvar Neoplasias
  Journal of Lower Genital Tract Disease, 11, 8-11 (2007).
• Boggess, JF.
  Robotics in Gynecologic Oncology: Establishing a New Surgical Paradigm.
  J Robotic Surg. 2007, 1 (1).
• Brewster WR
  Could a pelvic and abdominal symptom index assist in early detection of ovarian cancer?
  Nat Clin Pract Oncol. 2007 Jun;4(6):338-9.
• Bull-Phelps SL, Garner EI, Walsh CS, Gehrig PA, Miller DS, Schorge JO. 
  Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
  Gynecol Oncol 2007;107:316-9.
• Clarke-Pearson DL. 
  Complications of Disease and Therapy.
  In Clinical Gynecologic Oncology, Seventh Edition.  (DiSaia PJ, Creasman WT, eds).  Mosby/Elsevier, 2007.
• Clarke-Pearson DL.
  Surgical Complications.
  In Precis, An update in Obstetrics and Gynecology, 3rd Edition, American College of Obstetricians and Gynecologists, Washington DC, 2007.Havrilesky L, Cragun JM, Calingaert B, Alvarez Secord A, Valea FA, Clarke-Pearson DL, Berchuck A, Soper JT
  The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
  Gynecol Oncol 104: 401-5, 2007.
• Havrilesky L, Secord A, Bae-Jump V, Ayeni T, Calingaert B, Clarke-Pearson DL, Berchuck A, Gehrig PA.
  Outcomes in surgical stage I uterine papillary serous carcinoma.
  Gynecol Oncol, 2007; 105: 677-82
• Havrilesky, L, Alvarez-Secord, A, Bae-Jump, VL, Ayeni, T, Calingaert, B, Clarke-Pearson, D, Berchuck, A and Gehrig, PA
  Outcomes in surgical stage I uterine papillary serous carcinoma
  Gynecologic Oncology, 105, 688-82 (2007).
• Hunter MI, Ziogas A, Brewster WR. 
  Epithelial Ovarian Cancer and LMP Tumors Associated with a Lower Incidence of Second Primary Breast Cancer.
  American Journal of Clinical Oncology. 2007 Feb;30(1):1-7
• Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer N M, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW.
  American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer.
  J Clin Oncol. 2007; 25: 5490-5505
• Martino MA, Williamson E, Rajaram L, Lancaster JM, Hoffman MS, Maxwell GL, Clarke-Pearson DL.
  Defining practice patterns in Gynecologic Oncology to prevent pulmonary embolism and deep venous thrombosis.
  Gynecol Oncol, 2007;106: 439-445.
• Oei AL, Verheijen RH, Seiden MV, Benigno BB, Lopes A, Soper JT, Epenetos AA, Massuger LF
  Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival.
  Int J Cancer 12: 2710-14, 2007
• Rankins NC, Secord AA, Jewel E, Havrilesky LJ, Soper JT, Evans E
  Cost-effectiveness of adjuvant radiotherapy in intermediate-risk endometrial cancer.
  Gynecol Oncol 106: 388-93, 2007
• Rose P, Shamshad A, Watkins E, Thigpen JT, Deppe G, Clarke-Pearson DL, Insalaco S. 
  Long-Term Follow-Up of a Randomized Trial Comparing Concurrent Single Agent Cisplatin or Cisplatin-Based Combination Chemotherapy or Hydroxyurea During Pelvic Irradiation for Locally Advanced Cervical Cancer:  A Gynecologic Oncology Group Study.
  J Clin Oncol, 2007; 25: 2804-10
• Secord A, Havrilesky L, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson D, Gehrig PA.
  The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
  Gynecol Oncol 2007; 107:285-91.
• Secord AA, Havrilesky LJ, Carney ME, Soper JT, Clarke-Pearson DL, Rodriguez GC, Berchuck A. 
  Weekly low-does paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer.
  Int J Clin Oncol. 2007; 12: 31-36.
• Shafer A, Boggess JF
  The Robotic Revolution: Coming soon to a hospital near you?
  Contemporary OB/Gyn Technology. April 15, 2007.
• Soper JT, Alvarez Secord A, Havrilesky LJ, Berchuck A, Clarke-Pearson DL
  Comparison of Gracilis and Rectus Abdominis Myocutaneous Flap Neovaginal Reconstruction Performed During Radical Pelvic Surgery: Flap-Specific Morbidity.
  Int J Gynecol Cancer  17: 298-303, 2007.
• Soper JT, Creasman WT: 
  Gestational Trophoblastic Disease. 
  In:  (DiSaia PJ, Creasman WT, Eds)   Clinical Gynecologic Oncology, 7th Ed.  Mosby Elsevier, Philadelphia, p 201-234, 2007.
• Soper JT, Spillman M, Sampson JH, Kirkpatrick JP, Wolf JK, Clarke-Pearson DL
  High-risk gestational trophoblastic neoplasia with brain metastases:  Individualized multidisciplinary therapy in the management of four patients.
  Gynecol Oncol 104: 691-4, 2007.
• Spriggs DR, Brady M, Vaccarello L, Clarke-Pearson D, Burger RA, Mannel R,  Boggess JF, Lee RB, Hanly M. 
  A Phase III Randomized Trial of IV Cisplatin plus Paclitaxel as a 24- or 96-hour Infusion in Patients with selected Stage III or Stage IV Epithelial Ovarian Cancer:  A Gynecologic Oncology Group Study.
  J Clin Oncol, 2007; 25: 4466-72
• Westin SN, Skinner EN, Funk MJ, Gehrig PM, Van Le L. 
  Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer.
  Gynecol Oncol 2007; 105:414-7.
• Zhou, C, Boggess, JF, Bae-Jump, VL and Gehrig, PA
  Induction of apoptosis and inhibtion of telomerase activity by arsenic trioxide (AS2O3) in endometrial carcinoma cells
  Gynecologic Oncology, 105, 218-222 (2007).

2006

• Bae-Jump V, Zhou C, Gehrig PA, Whang Y, Boggess JF.
  Rapamycin inhibits hTERT telomerase mRNA expression independent of cell cycle arrest.
  Gynecologic Oncology 100:487-94, 2006.
• Boggess, JF, Zhou, C, Bae-Jump, VL, Gehrig, PA, and Whang, YE.
  Estrogen receptor dependent regulation of telomerase activity in human endometrial cancer cell lines.
  Gynecologic Oncology, 103, 417-424 (2006). PMID: 16690106
• Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Jaggernauth W, Jhingran A, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR 3rd, Morgan RJ Jr, Nag S, Partridge EE, Powell CB, Remmenga SW, Reynolds RK, Small W Jr, Soper J, Teng N; National Comprehensive Cancer Network. 
  Uterine cancers.
  J Natl Compr Canc Netw. 4:438-62, 2006
• Jones E, Alvarez Secord A, Prosnitz L, Samulski TV, Oleson Jr, Berchuck A, Clarke-Pearson D, Soper J, Dewhurst MW,  Vujaskovic Z: 
  Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.
  Int J Hyperthermia 22:161-72, 2006.
• Livasy CA, Reading FC, Moore DT, Boggess JF, Lininger RA. 
  EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma.
  Gynecol Oncol. 2006 Jan; 100(1):101-6.
• Lutman CV, Havrilesky LJ, Cragun JM, Alvarez Secord A, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT: 
  Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
  Gynecol Oncol 102:92-7, 2006.
• Maclaren JE, Gross RT, Sperry JA, Boggess JF.
  Impact of opioid use on outcomes of functional restoration.
  Clin J Pain. 2006 May; 22(4):392-8.
• Maxwell GL, Brown C, Rose GS, Thigpen TJ, Fleming G, Gallion H, Brewster WR. 
  Racial Disparity in Survival Among Patients with Advanced/Recurrent Endometrial Adenocarcinoma:  A Gynecologic Oncology Group Study.
  Cancer 2006 Nov 1;107(9):2197-205.
• Maxwell GL, Clarke-Pearson DL.
  Pulmonary embolism after major abdominal surgery in gynecologic oncology.
  Obstet Gynecol 2006; 108: 209
• Melgoza F, Brewster WR, Wilczynski S, Rutgers J.
  p16-Positive small cell neuroendocrine carcinoma of the endometrium.
  Int J Gynecol Pathol. 2006 Jul;25(3):252-6.
• Morgan RJ Jr, Alvarez RD, Armstrong DK, Chen LM, Copeland L, Fowler J, Gaffney DK, Gershenson D, Greer BE, Johnston C, Lancaster JM, Lele S, Matulonis U, Ozols RF, Remmenga SW, Sabbatini P, Soper J, Teng N; National Comprehensive Cancer Network. 
  Ovarian cancer. Clinical practice guidelines in oncology.
  J Natl Compr Canc Netw 4(9):912-39, 2006.
• Rinas AC, Mittman BW, Van Le L, Hartmann K, Cayless J, Singh HK. 
  Split-sample analysis of discarded cells from liquid-based pap smear sampling devices.
  Acta Cytologica 2006; 50: 55-62.
• Schimp VL, Bryant CS, Solomon LA, Hanna R, Ali-Fehmi R, Morris RT, Munkarah AR. 
  Impact of ethnicity on survival among African American patients with epithelial ovarian cancer.
  Gynecol Oncol. 2006 Apr;101(1) Supplement: S141-142. (Abstract)
• Schimp VL, Solomon LA, Hanna R, Bryant CS, Deppe G, Munkarah AR. 
  Charlson-age comorbidity index as predictor of outcome in patients with epithelial ovarian cancer.
  Gynecol Oncol. 2006 Apr;101(1) Supplement:S115-116. (Abstract)
• Soper JT
  Gestational trophoblastic disease.
  Obstet Gynecol 108:  176-87, 2006
• Sutton G, Axelrod JH, Bundy BN, Roy T, Homesley H, Lee RB, Gehrig PA, Zaino R.
  Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium. A phase II study of the Gynecologic Oncology Group.
  Gynecologic Oncology 100: 349-54, 2006.
• Theurer  CP, Taylor TH, Brewster WR, Anton-Culver H. 
  Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening.
  J Natl Med Assoc. 2006 Jan;98(1):51-7.
• Verheijen RH, Massuger LF, Benigno BB, Epenetos AA, Lopes A, Soper JT, Markowska J, Vyzula R, Jobling T, Stamp G, Spiegel G, Thurston D, Falke T, Lambert J, Seiden MV:
  Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission.
  J Clin Oncol 24(4):571-8, 2006.
• Zhou C, Bae-Jump VL, Whang YE, Gehrig PA, Boggess JF.
  The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.
  Gynecol Oncol. 2006 May; 101(2):305-10